0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Brief Communications |

Increased Allergen-Specific, Steroid-Sensitive γδ T Cells in Bronchoalveolar Lavage Fluid from Patients with Asthma

Fabrizio Spinozzi, MD; Elisabetta Agea, MD; Onelia Bistoni, BSc; Nicolino Forenza, MD; Alessandro Monaco, MD; Gabrio Bassotti, MD, PhD; Ildo Nicoletti, MD; Carlo Riccardi, MD; Fausto Grignani, MD; and Alberto Bertotto, MD
[+] Article and Author Information

From the University of Perugia, Perugia, Italy. Acknowledgments: The authors thank Ms. Judy Etherington for helpful suggestions in reviewing the English version of the manuscript. Grant Support: In part by MURST (Italian Ministry for University and Scientific Research). Requests for Reprints: Fabrizio Spinozzi, MD, Istituo Medicina Interna e Science Oncologiche, Universita di Perugia, Policlinico Monteluce, I-06100 Perugia, Italy. Current Author Addresses: Drs. Spinozzi, Agea, Nicoletti, and Grignani: Istituto di Medicina Interna e Scienze Oncologische, Universita di Perugia, Policlinico Monteluce, I-06100, Perugia, Italy.


Copyright ©2004 by the American College of Physicians


Ann Intern Med. 1996;124(2):223-228. doi:10.7326/0003-4819-124-2-199601150-00005
Text Size: A A A

Objective: To test the hypothesis that allergen-specific, steroid-sensitive γδ T lymphocytes are increased in bronchoalveolar lavage fluid of patients with asthma.

Design: Case series.

Setting: The outpatient allergy services at the University of Perugia, Perugia, Italy.

Patients: 12 untreated atopic patients (6 children and 6 adults) with mildly symptomatic chronic asthma were studied. Bronchoalveolar lavage fluid from 10 healthy nonsmoking volunteers and age-matched children with cystic fibrosis (n = 5) or anatomic malformation of the airways (n = 4) served as control samples.

Intervention: Three patients received treatment with deflazacort, 60 mg twice daily, for 1 week.

Measurements: CD3+, CD4+, and CD8+ T cells from patients and controls were examined by two-color flow cytometry for coexpression of Vδ1 and Vδ2 isoforms of the γδ T-cell receptor. In vitro pulmonary γδ T-cell proliferation in response to a specific allergen, the apoptotic death of these cells after incubation with 10−7 M dexamethasone, and bronchoalveolar lavage fluid T-lymphocyte composition before and after 1 week of deflazacort therapy were evaluated in 3 Dermatophagoides pteronyssinus-sensitive patients.

Results: The proportion of γδ T lymphocytes, primarily CD4+ or CD4 CD8 cells, was higher in asthmatic patients than in controls (P < 0.05 by one-way analysis of variance). Most lung γδ CD4+ lymphocytes expressed the γδ T-cell receptor Vδ1 chain. These cells proliferated in response to allergen stimulation, underwent steroid-induced apoptosis in vitro, and disappeared after systemic steroid treatment.

Conclusions: Allergen-specific, steroid-sensitive γδ T cells may be one of the cellular components involved in the airway inflammation that characterizes allergic bronchial asthma.

Figures

Grahic Jump Location
Figure 1.
Effects of systemic steroid therapy on bronchoalveolar lavage fluid T-cell composition and γδ T-cell survival in allergic bronchial asthma.bottomtop

After 1 week of deflazacort treatment (60 mg twice daily), the absolute numbers of bronchoalveolar lavage CD3+ TCRδ1+ and CD4+ Vδ1+ T-cell values decreased abruptly ( ), whereas the global TCR-αβ+ T-cell compartment expanded, and did not increase again when therapy was discontinued ( ). The absolute bronchoalveolar lavage lymphocyte numbers remained stable in all samples tested. Data depicted are from a single patient of the three studied.

Grahic Jump Location

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Related Point of Care
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)